GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » Gross Margin %
中文

Alphatec Holdings (Alphatec Holdings) Gross Margin % : 68.99% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Alphatec Holdings's Gross Profit for the three months ended in Dec. 2023 was $95.2 Mil. Alphatec Holdings's Revenue for the three months ended in Dec. 2023 was $138.0 Mil. Therefore, Alphatec Holdings's Gross Margin % for the quarter that ended in Dec. 2023 was 68.99%.

Warning Sign:

Alphatec Holdings Inc gross margin has been in long-term decline. The average rate of decline per year is -1.5%.


The historical rank and industry rank for Alphatec Holdings's Gross Margin % or its related term are showing as below:

ATEC' s Gross Margin % Range Over the Past 10 Years
Min: 63.31   Med: 66.74   Max: 70.92
Current: 64.32


During the past 13 years, the highest Gross Margin % of Alphatec Holdings was 70.92%. The lowest was 63.31%. And the median was 66.74%.

ATEC's Gross Margin % is ranked better than
67.96% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs ATEC: 64.32

Alphatec Holdings had a gross margin of 68.99% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Alphatec Holdings was -1.50% per year.


Alphatec Holdings Gross Margin % Historical Data

The historical data trend for Alphatec Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings Gross Margin % Chart

Alphatec Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.41 70.76 64.87 66.42 64.32

Alphatec Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.99 64.54 55.20 67.69 68.99

Competitive Comparison of Alphatec Holdings's Gross Margin %

For the Medical Devices subindustry, Alphatec Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alphatec Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Alphatec Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Alphatec Holdings's Gross Margin % falls into.



Alphatec Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Alphatec Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=310.2 / 482.262
=(Revenue - Cost of Goods Sold) / Revenue
=(482.262 - 172.059) / 482.262
=64.32 %

Alphatec Holdings's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=95.2 / 137.97
=(Revenue - Cost of Goods Sold) / Revenue
=(137.97 - 42.78) / 137.97
=68.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Alphatec Holdings  (NAS:ATEC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Alphatec Holdings had a gross margin of 68.99% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Alphatec Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alphatec Holdings (Alphatec Holdings) Business Description

Traded in Other Exchanges
Address
1950 Camino Vida Roble, Carlsbad, CA, USA, 92008
Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Executives
David Sponsel officer: EVP, Sales C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David M Demski director C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Patrick Miles director, officer: Executive Chairman 7475 LUSK BLVD., SAN DIEGO CA 92121
Tullis James L L director, 10 percent owner 100 FIRST STAMFORD PLACE, STAMFORD CT 06907
David H Mowry director 9775 TOLEDO, IRVINE CA 92618
Evan Bakst director 225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Tyson Eliot Marshall officer: GENERAL COUNSEL & CORP. SEC. 10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Craig E Hunsaker officer: See Remarks C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Paul Segal 10 percent owner 1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
L-5 Healthcare Partners, Llc 10 percent owner, other: Director by deputization 1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
John Todd Koning officer: Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Scott Lish officer: SVP, Development C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008